116 related articles for article (PubMed ID: 21246919)
1. Biochemical markers of iron status in hemodialysis patients.
Hukic F; Nuhbegovic S; Brkic S; Ostrvica E; Custendil-Delic S; Mustafic S
Med Arh; 2010; 64(4):219-22. PubMed ID: 21246919
[TBL] [Abstract][Full Text] [Related]
2. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
3. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency.
Miwa N; Akiba T; Kimata N; Hamaguchi Y; Arakawa Y; Tamura T; Nitta K; Tsuchiya K
Int J Lab Hematol; 2010 Apr; 32(2):248-55. PubMed ID: 19624802
[TBL] [Abstract][Full Text] [Related]
5. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
Saito M; Tsuchiya K; Ando M; Akiba T; Nihei H
Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
[TBL] [Abstract][Full Text] [Related]
6. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
7. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
Tarng DC; Huang TP; Chen TW
Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
[TBL] [Abstract][Full Text] [Related]
8. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
Ng HY; Chen HC; Pan LL; Tsai YC; Hsu KT; Liao SC; Chuang FR; Chen JB; Lee CT
Nephron Clin Pract; 2009; 111(4):c247-52. PubMed ID: 19293593
[TBL] [Abstract][Full Text] [Related]
9. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
Daschner M; Mehls O; Schaefer F
Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
Sany D; El Shahawi Y; Taha J
Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
[TBL] [Abstract][Full Text] [Related]
12. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
Raja R; Bloom E; Johnson R; Goldstein M
Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
[TBL] [Abstract][Full Text] [Related]
13. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
[TBL] [Abstract][Full Text] [Related]
14. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
Saltissi D; Sauvage D; Westhuyzen J
Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
[TBL] [Abstract][Full Text] [Related]
15. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Shimada K; Kanda F; Maeda K
Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
[No Abstract] [Full Text] [Related]
16. [Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis].
Eguchi A; Tsuchiya K; Tsukada M; Nitta K
Nihon Jinzo Gakkai Shi; 2010; 52(2):132-40. PubMed ID: 20415234
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy.
Asanuma M; Taguchi C; Uesaka H; Kumagai T; Seino K; Hosokawa H; Yamauchi F; Fujishima M; Murai K; Ishida Y
Lab Hematol; 2005; 11(2):124-30. PubMed ID: 16024336
[TBL] [Abstract][Full Text] [Related]
18. Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients.
Pollak VE; Lorch JA; Means RT
J Investig Med; 2001 Mar; 49(2):173-83. PubMed ID: 11288758
[TBL] [Abstract][Full Text] [Related]
19. [Clinical usefulness of the reticulocyte hemoglobin equivalent in chronic hemodialysis patients].
Eckhardt A; Freiberg MA; de la Fuente J; Douthat W; Capra R
Rev Fac Cien Med Univ Nac Cordoba; 2011; 68(2):51-5. PubMed ID: 22440657
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
